DE602005018222D1 - - Google Patents
Info
- Publication number
- DE602005018222D1 DE602005018222D1 DE602005018222T DE602005018222T DE602005018222D1 DE 602005018222 D1 DE602005018222 D1 DE 602005018222D1 DE 602005018222 T DE602005018222 T DE 602005018222T DE 602005018222 T DE602005018222 T DE 602005018222T DE 602005018222 D1 DE602005018222 D1 DE 602005018222D1
- Authority
- DE
- Germany
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004173174 | 2004-06-10 | ||
PCT/JP2005/011078 WO2005120493A1 (en) | 2004-06-10 | 2005-06-10 | Anticancer effect enhancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005018222D1 true DE602005018222D1 (de) | 2010-01-21 |
Family
ID=34970391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005018222T Active DE602005018222D1 (de) | 2004-06-10 | 2005-06-10 |
Country Status (8)
Country | Link |
---|---|
US (2) | US20080039521A1 (de) |
EP (1) | EP1778215B1 (de) |
JP (2) | JP4729503B2 (de) |
KR (1) | KR20070045187A (de) |
CN (1) | CN101001623B (de) |
DE (1) | DE602005018222D1 (de) |
ES (1) | ES2338022T3 (de) |
WO (1) | WO2005120493A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2731298T3 (es) | 2005-05-27 | 2019-11-14 | Univ North Carolina Chapel Hill | Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas |
JP2010024170A (ja) * | 2008-07-17 | 2010-02-04 | Hiroshi Maeda | 抗悪性腫瘍剤の腫瘍組織への局所送達増強剤 |
EP2334279A4 (de) * | 2008-10-16 | 2013-03-20 | Novan Inc | Stickoxid freisetzende partikel für mundpflegeanwendungen |
US9060934B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US20100111836A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US9050070B2 (en) * | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8551506B2 (en) * | 2008-10-31 | 2013-10-08 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US8725420B2 (en) * | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US20100111857A1 (en) | 2008-10-31 | 2010-05-06 | Boyden Edward S | Compositions and methods for surface abrasion with frozen particles |
US20100111834A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US8731840B2 (en) * | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8731841B2 (en) * | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9060926B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US20100111835A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US20100111831A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for surface abrasion with frozen particles |
US8762067B2 (en) * | 2008-10-31 | 2014-06-24 | The Invention Science Fund I, Llc | Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data |
US9072799B2 (en) * | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US20100111841A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc | Compositions and methods for surface abrasion with frozen particles |
US8603495B2 (en) * | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US9050317B2 (en) * | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8793075B2 (en) * | 2008-10-31 | 2014-07-29 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8518031B2 (en) * | 2008-10-31 | 2013-08-27 | The Invention Science Fund I, Llc | Systems, devices and methods for making or administering frozen particles |
US9050251B2 (en) | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US9072688B2 (en) * | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8721583B2 (en) * | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8788211B2 (en) * | 2008-10-31 | 2014-07-22 | The Invention Science Fund I, Llc | Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition |
US8613937B2 (en) * | 2008-10-31 | 2013-12-24 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US8798933B2 (en) | 2008-10-31 | 2014-08-05 | The Invention Science Fund I, Llc | Frozen compositions and methods for piercing a substrate |
US9060931B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
CA2771389C (en) | 2009-08-21 | 2019-04-09 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
EP4249001A3 (de) | 2009-08-21 | 2023-11-29 | Novan, Inc. | Topische gele |
US20110086234A1 (en) * | 2009-10-13 | 2011-04-14 | Nathan Stasko | Nitric oxide-releasing coatings |
CN102107009A (zh) * | 2009-12-25 | 2011-06-29 | 奇复康药物研发(苏州)有限公司 | 天然药物组分和一氧化氮供体的混合复方药物及其用途 |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
WO2012118829A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same |
JP5842367B2 (ja) * | 2011-04-07 | 2016-01-13 | ニプロ株式会社 | 抗癌剤増感剤 |
US20140088034A1 (en) * | 2011-05-11 | 2014-03-27 | Stc.Unm | NITRIC OXIDE/cGMP PATHWAY INHIBITION OF VLA-4 RELATED CELL ADHESION |
CN103130815B (zh) * | 2013-02-07 | 2015-10-07 | 浙江工业大学 | 一种单硝酸异山梨酯衍生物及其制备方法和应用 |
WO2015125934A1 (ja) | 2014-02-20 | 2015-08-27 | 国立大学法人大阪大学 | 抗癌剤の抗腫瘍効果の増強剤 |
US10214743B2 (en) | 2014-03-04 | 2019-02-26 | Hirofumi Yamamoto | Colorectal cancer drug, and method for predicting prognosis of colorectal cancer patient |
US11186640B2 (en) * | 2014-07-31 | 2021-11-30 | The University Of Western Australia | Method for the identification of immunotherapy-drug combinations using a network approach |
CN107823644B (zh) * | 2017-11-07 | 2021-03-02 | 福州大学 | 一种no供体化合物在制备抑制富含巯基分子的肿瘤细胞的侵袭和转移能力药物中的应用 |
CN109498818B (zh) * | 2018-05-25 | 2021-08-31 | 福州大学 | 一种产生NO的pH敏感脂质体及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU685178B2 (en) * | 1993-10-08 | 1998-01-15 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
EP0888458A4 (de) * | 1996-02-20 | 2004-05-06 | Sloan Kettering Institutefor C | Kombination von pkc-inhibitoren und therapeutischen agenzien zur behandlung von krebs |
IT1282686B1 (it) * | 1996-02-26 | 1998-03-31 | Nicox Sa | Composti in grado di ridurre la tossicita' da farmaci |
EP1251840A2 (de) | 2000-01-26 | 2002-10-30 | Cedars-Sinai Medical Center | Verwendung von kaliumkanalaktivatoren zur verabreichung von medikamenten an anormalen gehirnregionen und/oder bösartigen tumoren |
US7678391B2 (en) * | 2000-04-26 | 2010-03-16 | Queen's University At Kingston | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
US20020173538A1 (en) * | 2000-06-30 | 2002-11-21 | Ming-Shi Shiao | Method for sensitizing cancer cells to cancer therapies with a mevalonate-reducing compound |
JP2005527510A (ja) * | 2002-03-06 | 2005-09-15 | セレジー ファーマシューティカルズ インコーポレーティッド | 癌の治療において一酸化窒素模倣体を使用するための製剤および方法 |
-
2005
- 2005-06-10 EP EP05750803A patent/EP1778215B1/de not_active Expired - Fee Related
- 2005-06-10 JP JP2006551137A patent/JP4729503B2/ja active Active
- 2005-06-10 CN CN2005800271680A patent/CN101001623B/zh not_active Expired - Fee Related
- 2005-06-10 US US11/628,943 patent/US20080039521A1/en not_active Abandoned
- 2005-06-10 KR KR1020077000537A patent/KR20070045187A/ko active IP Right Grant
- 2005-06-10 WO PCT/JP2005/011078 patent/WO2005120493A1/en active Application Filing
- 2005-06-10 ES ES05750803T patent/ES2338022T3/es active Active
- 2005-06-10 DE DE602005018222T patent/DE602005018222D1/de active Active
-
2008
- 2008-12-22 US US12/318,061 patent/US8410175B2/en not_active Expired - Fee Related
-
2011
- 2011-03-04 JP JP2011047781A patent/JP2011144190A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1778215A1 (de) | 2007-05-02 |
JP2011144190A (ja) | 2011-07-28 |
JP2008501630A (ja) | 2008-01-24 |
US20090137683A1 (en) | 2009-05-28 |
US8410175B2 (en) | 2013-04-02 |
ES2338022T3 (es) | 2010-05-03 |
CN101001623B (zh) | 2010-11-17 |
JP4729503B2 (ja) | 2011-07-20 |
WO2005120493A1 (en) | 2005-12-22 |
EP1778215B1 (de) | 2009-12-09 |
WO2005120493A8 (en) | 2007-03-22 |
US20080039521A1 (en) | 2008-02-14 |
KR20070045187A (ko) | 2007-05-02 |
CN101001623A (zh) | 2007-07-18 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |